193 related articles for article (PubMed ID: 11805542)
1. Aminoglycoside nephrotoxicity: do time and frequency of administration matter?
Beauchamp D; Labrecque G
Curr Opin Crit Care; 2001 Dec; 7(6):401-8. PubMed ID: 11805542
[TBL] [Abstract][Full Text] [Related]
2. [Is it still possible to reduce the incidence of nephrotoxicity of aminoglycosides?].
Beauchamp D; Labrecque G; Bergeron MG
Pathol Biol (Paris); 1995 Nov; 43(9):779-87. PubMed ID: 8746100
[TBL] [Abstract][Full Text] [Related]
3. Extended-interval aminoglycoside administration for children: a meta-analysis.
Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.
Boyer A; Gruson D; Bouchet S; Clouzeau B; Hoang-Nam B; Vargas F; Gilles H; Molimard M; Rogues AM; Moore N
Drug Saf; 2013 Apr; 36(4):217-30. PubMed ID: 23508544
[TBL] [Abstract][Full Text] [Related]
6. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
Koo J; Tight R; Rajkumar V; Hawa Z
Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
[TBL] [Abstract][Full Text] [Related]
7. What is the evidence for once-daily aminoglycoside therapy?
Barclay ML; Begg EJ; Hickling KG
Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
Croes S; Koop AH; van Gils SA; Neef C
Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
[TBL] [Abstract][Full Text] [Related]
9. [Aminoglycoside-induced nephrotoxicity].
Fabrizii V; Thalhammer F; Hörl WH
Wien Klin Wochenschr; 1997 Nov; 109(21):830-5. PubMed ID: 9454436
[TBL] [Abstract][Full Text] [Related]
10. [Daily single-dose aminoglycoside administration. Therapeutic and economic benefits].
Knudsen LM; Frimodt-Møller N; Hansen MT; Hippe E
Ugeskr Laeger; 1993 May; 155(19):1436-41. PubMed ID: 8316969
[TBL] [Abstract][Full Text] [Related]
11. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.
Mörike K; Schwab M; Klotz U
Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity and ototoxicity of aztreonam versus aminoglycoside therapy in seriously ill nonneutropenic patients.
Moore RD; Lerner SA; Levine DP
J Infect Dis; 1992 Apr; 165(4):683-8. PubMed ID: 1552197
[TBL] [Abstract][Full Text] [Related]
13. Management of aminoglycosides in the intensive care unit.
Radigan EA; Gilchrist NA; Miller MA
J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630
[TBL] [Abstract][Full Text] [Related]
14. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?
Barclay ML; Kirkpatrick CM; Begg EJ
Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956
[TBL] [Abstract][Full Text] [Related]
15. Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity?
Zhanel GG; Ariano RE
Ren Fail; 1992; 14(1):1-9. PubMed ID: 1561384
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
[TBL] [Abstract][Full Text] [Related]
17. Clinical issues surrounding once-daily aminoglycoside dosing in children.
Knoderer CA; Everett JA; Buss WF
Pharmacotherapy; 2003 Jan; 23(1):44-56. PubMed ID: 12523459
[TBL] [Abstract][Full Text] [Related]
18. Extended dosage intervals for aminoglycosides.
Rodman DP; Maxwell AJ; McKnight JT
Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
[TBL] [Abstract][Full Text] [Related]
19. [PK/PD modeling of aminoglycoside nephrotoxicity].
Rougier F; Corvaisier S; Ducher M; Claude D; Jelliffe RW; Maire P
Pathol Biol (Paris); 2003 Jun; 51(4):234-6. PubMed ID: 12853000
[TBL] [Abstract][Full Text] [Related]
20. Should aminoglycoside antibiotics be abandoned?
English WP; Williams MD
Am J Surg; 2000 Dec; 180(6):512-5; discussion 515-6. PubMed ID: 11182409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
